ADOM report 21

This 21st national Alcohol and Drug Outcome Measure (ADOM) report focuses on regional variation among tāngata whai ora accessing community alcohol and other drug (AOD) services who report recent involvement with amphetamine-type stimulants (ATS). ATS, particularly methamphetamine, is a national priority due to the range of harms it may cause people and communities (Ministry of Health, 2026; New Zealand Government, 2025). The intent of the 2022 health system regional transformation was to reduce inequities and improve outcomes, so it is important to look at ATS use and outcomes by region to determine what is working well and opportunities for improvement.

This report analyses data from non-government organisations (NGOs) and Health New Zealand | Te Whatu Ora services mandated to offer the ADOM to tāngata whai ora. It includes people with valid ADOM collections at treatment start, and matched pairs (where people had data collected at treatment start and end). Health New Zealand | Te Whatu Ora, (extracted on 26 April 2026) supplied the data from PRIMHD for Jan 2023 to Dec 2025.